The heart is a hollow, muscular organ in vertebrates, responsible for pumping blood through the blood vessels by repeated, rhythmic contractions. The term cardiac, as in cardiology, means – related to the heart – and comes from the Greek word, kardia, for heart.
Heart disease risk after breast cancer radiotherapy smaller than previously thought – Researchers have for the first time calculated by how much radiotherapy for breast cancer increases the risk of heart disease and the findings can now be used by doctors to help treat patients more appropriately.
Intermountain study finds length of DNA strands can predict life expectancy — Findings may help patients at risk – Can the length of strands of DNA in patients with heart disease predict their life expectancy? Researchers from the Intermountain Heart Institute at Intermountain Medical Center in Salt Lake City, who studied the DNA of more that 3,500 patients with heart disease, say yes it can.
Cleveland Clinic research shows anemia drug does not improve health of anemic heart failure patients — Phase 3 findings published in NEJM provide answers about treatment with darbepoetin alfa – Researchers from Cleveland Clinic and Sweden-based Sahlgrenska University Hospital have found that a commonly used drug to treat anemia in heart failure patients – darbepoetin alfa – does not improve patients’ health, nor does it reduce their risk of death from heart failure.
Cholesterol levels rise, fall with changing seasons — Shifts in metabolism, behaviors and other factors at work – Cholesterol levels seem to fluctuate significantly with the turning seasons, which may leave some people with borderline high cholesterol at greater cardiovascular risk during the winter months, showing heart attacks and heart-related deaths increase during the winter months.
Clogged heart arteries can foreshadow stroke — American Heart Association Rapid Access Journal Report – Blockages in your heart arteries could mean you’re more likely to have a stroke, even if you’re considered low risk. A new study raises the need for intensified interdisciplinary efforts for providing adequate disease prevention and management strategies for stroke.
US FDA approves new treatment for late-stage breast cancer – Kadcyla (ado-trastuzumab emtansine) – a new therapy for patients with HER2-positive, late-stage (metastatic) breast cancer is approved by US FDA. Breast cancer is the second leading cause of cancer-related death among women. Almost 20 percent of breast cancers have increased amounts of the HER2 protein.
Reducing sodium consumption could save 280,000 to 500,000 lives in the United States over 10 years. — Americans consume about 3,600 mg of sodium per day ? more than twice the recommended limit. – Less sodium in the U.S. diet could save 280,000 to 500,000 lives over 10 years, according to new research in the American Heart Association journal Hypertension.
The Nutrition Facts Label: Helping Americans Make Heart-Healthy Choices – February is American Heart Month, and the U.S. Food and Drug Administration has a tool to help you achieve a heart-healthy lifestyle. It?s called the Nutrition Facts Label, and it can be found on all packaged foods and beverages.
Next-generation CT scanner provides better images with minimal radiation – A new computed tomography (CT) scanner substantially reduces potentially harmful radiation while still improving overall image quality. National Institutes of Health researchers, along with engineers at Toshiba Medical Systems, worked on the scanner.
US FDA approves new orphan drug Kynamro to treat inherited cholesterol disorder – Kynamro – mipomersen sodium – injection approved as an addition to lipid-lowering medications and diet to treat patients with a rare type of high cholesterol called homozygous familial hypercholesterolemia (HoFH). Kynamro is approved by the U.S. Food and Drug Administration.
US FDA approves three new drug treatments for type 2 diabetes – Nesina, Kazano, and Oseni – The U.S. Food and Drug Administration approved three new related products for use with diet and exercise to improve blood sugar control in adults with type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin and metformin hydrochloride) tablets, and Oseni (alogliptin and pioglitazone) tablets.
Kidney disease accounts for most of the increased risk of dying early among diabetics — Preventing and treating kidney disease in those with diabetes could save lives – One in every 10 Americans has diabetes, and a third or more of those with the condition will develop kidney disease. That means almost 3 percent of Americans suffer from chronic kidney disease.
